These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32268295)

  • 1. Peptide hormone analysis in diagnosis and treatment of Differences of Sex Development: joint position paper of EU COST Action 'DSDnet' and European Reference Network on Rare Endocrine Conditions.
    Johannsen TH; Andersson AM; Ahmed SF; de Rijke YB; Greaves RF; Hartmann MF; Hiort O; Holterhus PM; Krone NP; Kulle A; Ljubicic ML; Mastorakos G; McNeilly J; Pereira AM; Saba A; Wudy SA; Main KM; Juul A
    Eur J Endocrinol; 2020 Jun; 182(6):P1-P15. PubMed ID: 32268295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 'DSDnet'.
    Kulle A; Krone N; Holterhus PM; Schuler G; Greaves RF; Juul A; de Rijke YB; Hartmann MF; Saba A; Hiort O; Wudy SA;
    Eur J Endocrinol; 2017 May; 176(5):P1-P9. PubMed ID: 28188242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GENETICS IN ENDOCRINOLOGY: Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’.
    Audi L; Ahmed SF; Krone N; Cools M; McElreavey K; Holterhus PM; Greenfield A; Bashamboo A; Hiort O; Wudy SA; McGowan R;
    Eur J Endocrinol; 2018 Oct; 179(4):R197-R206. PubMed ID: 30299888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Laboratory Assessment in Disorders of Sex Development through a Multidisciplinary Network.
    Hannema SE; de Rijke YB
    Sex Dev; 2018; 12(1-3):135-139. PubMed ID: 29339667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in Reproductive Hormones During Mini-Puberty in Infants With Normal and Disordered Sex Development.
    Johannsen TH; Main KM; Ljubicic ML; Jensen TK; Andersen HR; Andersen MS; Petersen JH; Andersson AM; Juul A
    J Clin Endocrinol Metab; 2018 Aug; 103(8):3028-3037. PubMed ID: 29917083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing gaps in care of people with conditions affecting sex development and maturation.
    Hiort O; Cools M; Springer A; McElreavey K; Greenfield A; Wudy SA; Kulle A; Ahmed SF; Dessens A; Balsamo A; Maghnie M; Bonomi M; Dattani M; Persani L; Audi L;
    Nat Rev Endocrinol; 2019 Oct; 15(10):615-622. PubMed ID: 31406344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal evaluation in relation to phenotype and genotype in 286 patients with a disorder of sex development from Indonesia.
    Juniarto AZ; van der Zwan YG; Santosa A; Ariani MD; Eggers S; Hersmus R; Themmen AP; Bruggenwirth HT; Wolffenbuttel KP; Sinclair A; White SJ; Looijenga LH; de Jong FH; Faradz SM; Drop SL
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):247-57. PubMed ID: 26935236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Categorization of differences of sex development among Egyptian children and the role of antimullerian hormone and inhibin B.
    Abdelghaffar S; AbdelMoneam EN; Hassanein SA; Radwan NA; Mira MF
    Front Endocrinol (Lausanne); 2022; 13():1072399. PubMed ID: 36686446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibin B is lower and anti-Müllerian hormone is similar in serum of men with spinal cord injuries compared to controls.
    Ibrahim E; Aballa TC; Roudebush WE; Lynne CM; Brackett NL
    Syst Biol Reprod Med; 2015 Apr; 61(2):72-7. PubMed ID: 25581422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
    Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
    Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Under-reported aspects of diagnosis and treatment addressed in the Dutch-Flemish guideline for comprehensive diagnostics in disorders/differences of sex development.
    Bever YV; Brüggenwirth HT; Wolffenbuttel KP; Dessens AB; Groenenberg IAL; Knapen MFCM; De Baere E; Cools M; van Ravenswaaij-Arts CMA; Sikkema-Raddatz B; Claahsen-van der Grinten H; Kempers M; Rinne T; Hersmus R; Looijenga L; Hannema SE
    J Med Genet; 2020 Sep; 57(9):581-589. PubMed ID: 32303604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of DSD training schools organized by cost action BM1303 "DSDnet".
    Bertalan R; Lucas-Herald A; Kolesinska Z; Berra M; Cools M; Balsamo A; Hiort O
    Orphanet J Rare Dis; 2018 Dec; 13(1):227. PubMed ID: 30563557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex biological pattern of fertility hormones in children and adolescents: a study of healthy children from the CALIPER cohort and establishment of pediatric reference intervals.
    Konforte D; Shea JL; Kyriakopoulou L; Colantonio D; Cohen AH; Shaw J; Bailey D; Chan MK; Armbruster D; Adeli K
    Clin Chem; 2013 Aug; 59(8):1215-27. PubMed ID: 23637248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic approach in 46, XY DSD: an endocrine society of bengal (ESB) consensus statement.
    Baidya A; Basu AK; Bhattacharjee R; Biswas D; Biswas K; Chakraborty PP; Chatterjee P; Chowdhury S; Dasgupta R; Ghosh A; Ghosh S; Giri D; Goswami S; Maisnam I; Maiti A; Mondal S; Mukhopadhyay P; Mukhopadhyay S; Mukhopadhyay S; Pal SK; Pandit K; Ray S; Chowdhury BR; Raychaudhuri M; Raychaudhuri P; Roy A; Sahana PK; Sanyal D; Sanyal T; Saraogi RK; Sarkar D; Sengupta N; Singh AK; Sinha A
    J Pediatr Endocrinol Metab; 2023 Jan; 36(1):4-18. PubMed ID: 36424806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The laboratory in the multidisciplinary diagnosis of differences or disorders of sex development (DSD): III) Biochemical and genetic markers in the 46,XYIV) Proposals for the differential diagnosis of DSD.
    Granada ML; Audí L
    Adv Lab Med; 2021 Nov; 2(4):494-515. PubMed ID: 37360892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular anti-Müllerian hormone: clinical applications in DSD.
    Josso N; Rey R; Picard JY
    Semin Reprod Med; 2012 Oct; 30(5):364-73. PubMed ID: 23044872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating mutations in the luteinizing hormone receptor gene: a human model of non-follicle-stimulating hormone-dependent inhibin production and germ cell maturation.
    Soriano-Guillen L; Mitchell V; Carel JC; Barbet P; Roger M; Lahlou N
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3041-7. PubMed ID: 16684832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Sertoli cell hormones inhibin-B and anti Müllerian hormone have different patterns of secretion in prepubertal cryptorchid boys.
    Cortes D; Clasen-Linde E; Hutson JM; Li R; Thorup J
    J Pediatr Surg; 2016 Mar; 51(3):475-80. PubMed ID: 26452703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the health-related management of people with differences of sex development.
    Jürgensen M; Rapp M; Döhnert U; Frielitz FS; Ahmed F; Cools M; Thyen U; Hiort O
    Endocrine; 2021 Mar; 71(3):675-680. PubMed ID: 33515437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.